(Q38150059)

29 August 2017

Interferon α/β receptor knockout mice as a model to study bluetongue virus infection (English)

1 reference

29 August 2017

0 references

0 references

Alejandro Marín-López

object named as

Alejandro Marín-López

series ordinal

3

0 references

Javier Ortego

object named as

Javier Ortego

series ordinal

1

0 references

author name string

Francisco de la Poza

series ordinal

2

1 reference

29 August 2017

4 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

182

1 reference

29 August 2017

35-42

1 reference

Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV)

29 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Dynamics of viral spread in bluetongue virus infected calves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Experimental oral infection of bluetongue virus serotype 8 in type I interferon receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Determinants of bluetongue virus virulence in murine models of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Enhanced proinflammatory cytokine activity during experimental bluetongue virus-1 infection in Indian native sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Establishment and application of hepatitis B virus persistent replication model in IFNAR(-/-) mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

The role of endothelial cell-derived inflammatory and vasoactive mediators in the pathogenesis of bluetongue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Bluetongue virus infection activates bovine monocyte-derived macrophages and pulmonary artery endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Epizootic hemorrhagic disease virus infection of type I interferon receptor deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Laboratory tests for evaluating the level of attenuation of bluetongue virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

The preparation of purified bluetongue virus group antigen for use as a diagnostic reagent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Bluetongue Virus Targets Conventional Dendritic Cells in Skin Lymph

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

36 Induction of interferon with bluetongue virus in various cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Bluetongue in Eurasian lynx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Role of neutralising antibody in passive immunity to bluetongue infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Experimental reproduction of severe bluetongue in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

The pathology and pathogenesis of bluetongue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

The pathogenesis of experimental bluetongue virus infection of calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

7 January 2021

African horse sickness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Functional role of type I and type II interferons in antiviral defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

DNA vaccination against La Crosse virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Bluetongue virus infection: pathologic responses of nervous systems in sheep and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Bluetongue Epidemiology in the European Union

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Potential role of proinflammatory cytokines in the pathogenetic mechanisms of vascular lesions in goats naturally infected with bluetongue virus serotype 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Comparative study of clinical courses, gross lesions, acute phase response and coagulation disorders in sheep inoculated with bluetongue virus serotype 1 and 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Bluetongue virus: virology, pathogenesis and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Type I IFN modulates the immune response induced by DNA vaccination to pseudorabies virus glycoprotein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

The measurement of three cytokine transcripts in naïve and sensitized ovine peripheral blood mononuclear cells following in vitro stimulation with bluetongue virus serotype-23.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

The role of interferons in rotavirus infections and protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Intrahepatic application of suicide gene-armed measles virotherapeutics: a safety study in transgenic mice and rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Schmallenberg virus infection of adult type I interferon receptor knock-out mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Virological and pathological findings in Bluetongue virus serotype 8 infected sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.09.038

10.1016/J.VIRUSRES.2013.09.038

7 January 2021

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

24100234